13.30
-0.4(-2.92%)
Currency In USD
| Previous Close | 13.7 |
| Open | 13.5 |
| Day High | 13.71 |
| Day Low | 13.15 |
| 52-Week High | 14.76 |
| 52-Week Low | 6.55 |
| Volume | 7,993 |
| Average Volume | 4,351 |
| Market Cap | 66M |
| PE | 83.13 |
| EPS | 0.16 |
| Moving Average 50 Days | 13.21 |
| Moving Average 200 Days | 10.8 |
| Change | -0.4 |
If you invested $1000 in Daxor Corporation (DXR) 10 years ago, it would be worth $1,768.65 as of January 18, 2026 at a share price of $13.3. Whereas If you bought $1000 worth of Daxor Corporation (DXR) shares 5 years ago, it would be worth $1,003.77 as of January 18, 2026 at a share price of $13.3.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Daxor Fuels Growth with Three New Facility Adoptions and Deployment of Next-Generation BVA Analyzer
GlobeNewswire Inc.
Nov 25, 2025 1:00 PM GMT
Continued Integration of ezBVA Lab Service and On-Site Analyzer Deployment Signals Accelerating Market Traction Oak Ridge, TN, Nov. 25, 2025 (GLOBE NEWSWIRE) -- Daxor Corporation (Nasdaq: DXR), the global leader in blood volume measurement technolo
Daxor CEO Michael Feldschuh to Engage Investors at Exclusive Maxim Growth Summit
GlobeNewswire Inc.
Oct 21, 2025 12:00 PM GMT
Summit Features a Select Group of 40 Promising Healthcare Companies at Premier Small-Cap Investor Event OAK RIDGE, TN, Oct. 21, 2025 (GLOBE NEWSWIRE) -- Daxor Corporation (Nasdaq: DXR), the global leader in blood volume measurement technology, toda
Daxor’s New BVA Technology To Be Showcased At MedAxiom CV Transforum Fall '25
GlobeNewswire Inc.
Oct 15, 2025 12:00 PM GMT
OAK RIDGE, Tenn., Oct. 15, 2025 (GLOBE NEWSWIRE) -- Daxor Corporation (NASDAQ: DXR), the global leader in blood volume measurement technology, today announces it will be exhibiting at the MedAxiom Cardiovascular (CV) Transforum Fall’25 Conference b